However, less than 50% of breast cancer patients are detected with the elevation of serum CA15–3 and CEA levels, and CA125 is used mainly for detection of ovarian cancer, which is less specific in other cancer types [37, 38]. The gene discussed is CEACAM5; the disease is ovarian cancer.